Lee, M. A. (2012). Comparison of Efficacy Between Gemcitabine/Erlotinib (GE) and Gemcitabine/Capecitabine (GX) in Unresectable Pancreatic Cancer: Retrospective, Single Center Experience, Final Report. International Society of Gastrointestinal Oncology.
Styl ChicagoLee, Myung- Ah. Comparison of Efficacy Between Gemcitabine/Erlotinib (GE) and Gemcitabine/Capecitabine (GX) in Unresectable Pancreatic Cancer: Retrospective, Single Center Experience, Final Report. International Society of Gastrointestinal Oncology, 2012.
Citace podle MLALee, Myung- Ah. Comparison of Efficacy Between Gemcitabine/Erlotinib (GE) and Gemcitabine/Capecitabine (GX) in Unresectable Pancreatic Cancer: Retrospective, Single Center Experience, Final Report. International Society of Gastrointestinal Oncology, 2012.